Greene Kimberly S, of Southern Co, sells $2.4m in stock

Southern Co reported Q4 2025 adjusted EPS of $0.55 vs $0.50 year-over-year and full-year adjusted EPS of $4.30, hitting the top end of guidance (up from $4.05 in 2024). Chairman Kimberly S. Greene sold 25,000 shares at $96.67 for $2,416,750 and now directly owns 103,602 shares. The company issued $1.3B of Series 2026A 6.00% junior subordinated notes due April 1, 2058 as part of financing. Analysts upgraded or raised targets (Evercore to Outperform, PT $111 from $103; TD Cowen PT $112 from $108; KeyBanc to Sector Weight), supporting a constructive near-term outlook.

Analysis

Management’s decision to tap long-dated, subordinated funding reads as a pre-emptive move to lock liquidity for multi-year capital programs; that strategy reduces refinancing risk but increases structural leverage in the instrument sleeve that sits between equity and senior debt. Secondary effects: this issuance will reset the marginal financing curve for similarly sized utilities — expect peers with cleaner balance sheets to underwrite new projects at a lower all-in cost while hybrids and preferreds rerate to the new baseline.

The recent wave of buy-side upgrades is less about near-term earnings and more about a narrative shift: the company is being reclassified from a ‘defensive yield’ to a ‘managed-growth utility’ in models that now give greater weight to project completion and state-level rate recovery. That rerating is conditional — a single regulatory setback or sizeable cost overrun would rapidly reverse multiple expansion and put pressure on subordinated spread widening and credit ratios.

Insider liquidity events, when considered alongside the financing move, mildly raise the bar for near-term execution: the market will be quick to punish any slippage in project timelines or regulator outcomes. Time horizons break down cleanly — bond/credit moves settle in days-weeks, analyst-driven equity rerating plays out over 3–12 months, and the ultimate value accrues (or evaporates) over the multi-year statutory/regulatory cycle tied to capital projects.

Key Decisions for Investors

• Buy subordinated/hybrid paper on pullbacks (SO subordinated notes): if new-issue spread over the utility curve exceeds ~300–350bps, take a starter position sized to 3–5% of credit sleeve and hedge duration via a receive-fixed interest-rate swap; target gross carry + optional tightening = 5–8% IRR over 2–4 years, stop-loss if spread widens another 75bps.
• Equity pair trade — long SO / short NEE (12 months): size 1:0.6 (dollar neutral) to capture a potential re-rating of regulated growth versus a pure merchant/growth multiple contraction; target 15–25% relative outperformance, cut at 8–10% relative adverse move or any confirmed regulatory disallowance.
• Options collar to express convexity (6–12 months): buy medium-dated calls on SO funded by selling short-dated, out-of-the-money calls to collect premium; use this to lever exposure to rerating while capping near-term downside — risk = net premium paid, reward = intrinsic rerating upside.
• Long industrial suppliers to grid and nuclear capex (examples: ETN, ABB, ACM) on 6–18 month horizon: these names are first-order beneficiaries of persistent capex plans even if one utility underperforms; target 20–30% upside on successful order flow visibility, monitor backlog disclosures and vendor margin guidance as primary catalysts.